Dynavax Technologies (DVAX)

$15.50 0.00 (N/A)
Market Cap 1.82B
Revenue (ttm) 277.25M
Net Income (ttm) 27.31M
EPS (ttm) N/A
PE Ratio 53.45
Forward PE 24.80
Profit Margin 9.85%
Debt to Equity Ratio 0.08
Volume 7,106,100
Avg Vol 3,463,082
Day's Range N/A - N/A
Shares Out 117.43M
Stochastic %K 31%
Beta 0.97
Analysts Strong Sell
Price Target $24.33

Company Profile

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccin...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 510 848 5100
Fax: 510 848 1327
Address:
2100 Powell Street, Suite 720, EmeryVille, United States
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 16 at 6:55 PM
$DVAX RSI: 20.00, MACD: 0.3644 Vol: 0.08, MA20: 15.55, MA50: 13.85 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Tmon1813
Tmon1813 Feb. 13 at 2:12 PM
$DVAX let’s see if $RUM can offer a return
0 · Reply
Noobnr1
Noobnr1 Feb. 13 at 10:06 AM
$DVAX bye bye guys… not even break even after years 😢
1 · Reply
3889HH2isj
3889HH2isj Feb. 11 at 1:43 PM
$MRNA is facing a "Refusal-to-File" from the FDA for its flu vaccine, signaling a massive regulatory failure and a major blow to its future pipeline. The strategic capture of $DVAX by Sanofi and the rise of mucosal/oral alternatives are rapidly eroding Moderna's competitive moat in the respiratory sector. Analysts have already begun slashing price targets following the news, with new ranges shifting as low as $22-$26. With a brutal Q4 earnings call this Friday, the market is pricing in a terminal decline of the mRNA hype.
0 · Reply
Tom2424
Tom2424 Feb. 11 at 9:44 AM
$VXRT $PFE $SNY $MRNA FDA RTF for Moderna flu confirms systemic mRNA cannot overcome 'Antigenic Shunt'. Mucosal IgA is the new benchmark. 🧬 In 2024, Lutnick (White House advisor/former Cantor CEO) pushed "2 Billion doses" while Oppenheimer ATMs and indirect institutional backdoors capped $VXRT & $DVAX price discovery. Massive conflict? Sanofi’s Feb 10 $DVAX capture is a strategic backdoor to VAAST tech. Probable SEC TCRs are now surfacing regarding these conflicts & suppressed N=5000 trial metrics (8% Delta). The "Sentinel Ultimatum" is ticking. ⏳ Bourla (Pfizer) is cornered; mRNA-1010 failure leaves $PFE with no respiratory moat. He has 2-4 weeks to intercept $VXRT before N=400 data makes the price prohibitive & Sanofi integrates. Hostile bid incoming to block the French capture of US-funded IP? The biology of the oral pill is winning. #VAAST #Vaxart #Pfizer #Sanofi #Lutnick #FDA #StockMarket #BioTech #Trump #Sentinel
3 · Reply
VictorJung
VictorJung Feb. 11 at 12:41 AM
$DVAX this was my first 6 figure profit so i really should look on it kindly. Good luck, thanks for the good hang time here longs
1 · Reply
RoutineMidnight5779
RoutineMidnight5779 Feb. 10 at 8:25 PM
$VXRT $DVAX $SNY https://finance.yahoo.com/news/press-release-sanofi-completes-acquisition-140000488.html
0 · Reply
Stanplain
Stanplain Feb. 10 at 7:15 PM
$DVAX and so it ends, good luck to all A toast to monkey man who made this call
0 · Reply
Tmon1813
Tmon1813 Feb. 10 at 5:10 PM
$DVAX made some money with this ticker. I’ve enjoyed interacting with most on this board. I wish you guys good luck and green candles to all!
0 · Reply
KWalzz
KWalzz Feb. 10 at 3:44 PM
$DVAX made me a 7-digit gain over a period of a decade. I always wanted to print a 2 as first digit but it stayed a 1. nevertheless much money made with disgusting guys, especially Scott Myers, one of the most disgusting guys in bio world. I will watch his footsteps closely though, where this guy wanders crooks wander, and with them some opps arise from time to time, LMAO. I wish all the friendly ones here the best for their future trades. GOOD LUCK TO ALL THE GOOD GUYS HERE !!
1 · Reply
Latest News on DVAX
Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

Feb 4, 2026, 6:15 PM EST - 21 days ago

Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

ADT ARWR CIEN DAY OSW

Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying

Dec 24, 2025, 11:05 AM EST - 2 months ago

Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion.

Dec 24, 2025, 7:59 AM EST - 2 months ago

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion.

SNY

Sanofi to acquire Dynavax for $2.2B, sending shares higher by 37%

Dec 24, 2025, 6:49 AM EST - 2 months ago

Sanofi to acquire Dynavax for $2.2B, sending shares higher by 37%

Sanofi to acquire US biotech Dynavax for $2.2 billion

Dec 24, 2025, 3:08 AM EST - 2 months ago

Sanofi to acquire US biotech Dynavax for $2.2 billion

SNY

Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal

Dec 24, 2025, 1:49 AM EST - 2 months ago

Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal

SNY

Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline

Dec 24, 2025, 1:23 AM EST - 2 months ago

Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline

Dec 24, 2025, 1:15 AM EST - 2 months ago

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline

SNY

Dynavax to Participate at the 8th Annual Evercore Healthcare Conference

Nov 19, 2025, 4:01 PM EST - 3 months ago

Dynavax to Participate at the 8th Annual Evercore Healthcare Conference

Dynavax Technologies Corporation (DVAX) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 10:31 PM EST - 4 months ago

Dynavax Technologies Corporation (DVAX) Q3 2025 Earnings Call Transcript

Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program

Nov 5, 2025, 4:01 PM EST - 4 months ago

Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program

VXRT

Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program

Nov 5, 2025, 4:00 PM EST - 4 months ago

Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program

VXRT

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025

Oct 22, 2025, 4:01 PM EDT - 4 months ago

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial

Oct 21, 2025, 4:01 PM EDT - 4 months ago

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial

3 Of My Favorite Biotech Stocks Under $10

Sep 29, 2025, 1:15 PM EDT - 5 months ago

3 Of My Favorite Biotech Stocks Under $10

FOLD MRNA NUVB PFE

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

Aug 27, 2025, 4:05 PM EDT - 6 months ago

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study

Aug 21, 2025, 8:22 AM EDT - 6 months ago

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study

GSK

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

Aug 21, 2025, 8:00 AM EDT - 6 months ago

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

Dynavax Technologies: A Dip To Accumulate

Aug 11, 2025, 8:41 AM EDT - 7 months ago

Dynavax Technologies: A Dip To Accumulate

Dynavax Technologies Corporation (DVAX) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 10:51 PM EDT - 7 months ago

Dynavax Technologies Corporation (DVAX) Q2 2025 Earnings Call Transcript

Dynavax Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:00 PM EDT - 7 months ago

Dynavax Reports Second Quarter 2025 Financial Results

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Jul 29, 2025, 4:02 PM EDT - 7 months ago

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Dynavax elects all four of its nominees after Deep Track proxy fight

Jun 11, 2025, 12:14 PM EDT - 9 months ago

Dynavax elects all four of its nominees after Deep Track proxy fight

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Jun 11, 2025, 11:01 AM EDT - 9 months ago

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Jun 9, 2025, 8:30 AM EDT - 9 months ago

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Jun 9, 2025, 7:30 AM EDT - 9 months ago

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Dynavax Comments on Glass Lewis Recommendation

Jun 4, 2025, 4:59 PM EDT - 9 months ago

Dynavax Comments on Glass Lewis Recommendation

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Jun 4, 2025, 9:27 AM EDT - 9 months ago

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

May 28, 2025, 4:10 PM EDT - 9 months ago

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

Deep Track Capital Comments on ISS Recommendation

May 23, 2025, 6:12 PM EDT - 9 months ago

Deep Track Capital Comments on ISS Recommendation

ISS backs Dynavax directors in board fight with Deep Track Capital

May 23, 2025, 1:54 PM EDT - 9 months ago

ISS backs Dynavax directors in board fight with Deep Track Capital

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

May 23, 2025, 1:44 PM EDT - 9 months ago

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

May 21, 2025, 11:48 PM EDT - 10 months ago

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

May 15, 2025, 4:00 PM EDT - 10 months ago

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

May 12, 2025, 7:30 AM EDT - 10 months ago

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

May 7, 2025, 4:45 PM EDT - 10 months ago

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:34 PM EDT - 10 months ago

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

May 6, 2025, 4:01 PM EDT - 10 months ago

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

May 6, 2025, 8:00 AM EDT - 10 months ago

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

May 1, 2025, 8:00 AM EDT - 10 months ago

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Apr 29, 2025, 7:30 AM EDT - 10 months ago

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Apr 22, 2025, 4:00 PM EDT - 11 months ago

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Apr 21, 2025, 4:05 PM EDT - 11 months ago

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Apr 17, 2025, 7:15 AM EDT - 11 months ago

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Apr 16, 2025, 8:00 AM EDT - 11 months ago

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 16 at 6:55 PM
$DVAX RSI: 20.00, MACD: 0.3644 Vol: 0.08, MA20: 15.55, MA50: 13.85 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Tmon1813
Tmon1813 Feb. 13 at 2:12 PM
$DVAX let’s see if $RUM can offer a return
0 · Reply
Noobnr1
Noobnr1 Feb. 13 at 10:06 AM
$DVAX bye bye guys… not even break even after years 😢
1 · Reply
3889HH2isj
3889HH2isj Feb. 11 at 1:43 PM
$MRNA is facing a "Refusal-to-File" from the FDA for its flu vaccine, signaling a massive regulatory failure and a major blow to its future pipeline. The strategic capture of $DVAX by Sanofi and the rise of mucosal/oral alternatives are rapidly eroding Moderna's competitive moat in the respiratory sector. Analysts have already begun slashing price targets following the news, with new ranges shifting as low as $22-$26. With a brutal Q4 earnings call this Friday, the market is pricing in a terminal decline of the mRNA hype.
0 · Reply
Tom2424
Tom2424 Feb. 11 at 9:44 AM
$VXRT $PFE $SNY $MRNA FDA RTF for Moderna flu confirms systemic mRNA cannot overcome 'Antigenic Shunt'. Mucosal IgA is the new benchmark. 🧬 In 2024, Lutnick (White House advisor/former Cantor CEO) pushed "2 Billion doses" while Oppenheimer ATMs and indirect institutional backdoors capped $VXRT & $DVAX price discovery. Massive conflict? Sanofi’s Feb 10 $DVAX capture is a strategic backdoor to VAAST tech. Probable SEC TCRs are now surfacing regarding these conflicts & suppressed N=5000 trial metrics (8% Delta). The "Sentinel Ultimatum" is ticking. ⏳ Bourla (Pfizer) is cornered; mRNA-1010 failure leaves $PFE with no respiratory moat. He has 2-4 weeks to intercept $VXRT before N=400 data makes the price prohibitive & Sanofi integrates. Hostile bid incoming to block the French capture of US-funded IP? The biology of the oral pill is winning. #VAAST #Vaxart #Pfizer #Sanofi #Lutnick #FDA #StockMarket #BioTech #Trump #Sentinel
3 · Reply
VictorJung
VictorJung Feb. 11 at 12:41 AM
$DVAX this was my first 6 figure profit so i really should look on it kindly. Good luck, thanks for the good hang time here longs
1 · Reply
RoutineMidnight5779
RoutineMidnight5779 Feb. 10 at 8:25 PM
$VXRT $DVAX $SNY https://finance.yahoo.com/news/press-release-sanofi-completes-acquisition-140000488.html
0 · Reply
Stanplain
Stanplain Feb. 10 at 7:15 PM
$DVAX and so it ends, good luck to all A toast to monkey man who made this call
0 · Reply
Tmon1813
Tmon1813 Feb. 10 at 5:10 PM
$DVAX made some money with this ticker. I’ve enjoyed interacting with most on this board. I wish you guys good luck and green candles to all!
0 · Reply
KWalzz
KWalzz Feb. 10 at 3:44 PM
$DVAX made me a 7-digit gain over a period of a decade. I always wanted to print a 2 as first digit but it stayed a 1. nevertheless much money made with disgusting guys, especially Scott Myers, one of the most disgusting guys in bio world. I will watch his footsteps closely though, where this guy wanders crooks wander, and with them some opps arise from time to time, LMAO. I wish all the friendly ones here the best for their future trades. GOOD LUCK TO ALL THE GOOD GUYS HERE !!
1 · Reply
KWalzz
KWalzz Feb. 10 at 3:39 PM
$DVAX ok, it went through and this is good in the end. there were so many disgusting guys over at Dynavax that making money was double the fun it is elsewhere, LOL.
0 · Reply
aristocks
aristocks Feb. 10 at 3:37 PM
$SNY is this tanking for the recent acquisition of $DVAX or because the great results from $NKTR ??? Maybe both?
1 · Reply
freeze19
freeze19 Feb. 10 at 3:29 PM
$DVAX It's been fun. Thanks everyone for their contributions over the years
0 · Reply
zenon999
zenon999 Feb. 10 at 2:32 PM
$VXRT $DVAX DVAX is halted today, February 10, 2026, because the merger with Sanofi is finalized. The Halt: Trading was halted effective this morning (February 10) because the merger is moving into the final step where Sanofi acquires the remaining shares. ​Delisting: The ticker symbol DVAX will be formally delisted from the exchange shortly.
0 · Reply
LUCKY_Cool_Cat
LUCKY_Cool_Cat Feb. 10 at 2:12 PM
$VXRT $DVAX
0 · Reply
zenon999
zenon999 Feb. 10 at 2:03 PM
$VXRT $DVAX SEC filing confirms that enough shares have been tendered. $SNY will acquire DVAX https://www.sec.gov/Archives/edgar/data/1029142/000119312526043594/d12825dsctota.htm 84,680,752 shares have been tendered, representing 73.92% of the outstanding shares. DVAX shareholders will receive $15.50 for each share held. Following the Merger, DVAX will no longer be listed on the NASDAQ Global Select Market and will be deregistered under the Exchange Act.
1 · Reply
WALTERPAYTON34
WALTERPAYTON34 Feb. 10 at 11:49 AM
$DVAX $VXRT
0 · Reply
TwongStocks
TwongStocks Feb. 10 at 11:39 AM
$DVAX SEC filing confirms that enough shares have been tendered. $SNY will acquire DVAX https://www.sec.gov/Archives/edgar/data/1029142/000119312526043594/d12825dsctota.htm 84,680,752 shares have been tendered, representing 73.92% of the outstanding shares. DVAX shareholders will receive $15.50 for each share held. Following the Merger, DVAX will no longer be listed on the NASDAQ Global Select Market and will be deregistered under the Exchange Act.
0 · Reply
BUY_SNY
BUY_SNY Feb. 10 at 10:51 AM
$DVAX Time to BUY SNY 😁
0 · Reply
FreeBeerTomorrow
FreeBeerTomorrow Feb. 10 at 9:33 AM
$DVAX DVAX is halted today, February 10, 2026, because the merger with Sanofi is finalized. The Halt: Trading was halted effective this morning (February 10) because the merger is moving into the final step where Sanofi acquires the remaining shares. ​Delisting: The ticker symbol DVAX will be formally delisted from the exchange shortly.
0 · Reply
RoutineMidnight5779
RoutineMidnight5779 Feb. 10 at 8:31 AM
$VXRT $DVAX https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-67
1 · Reply
Dilly_Due
Dilly_Due Feb. 10 at 4:08 AM
$VXRT $DVAX $SNY Anyone know if the SNY/DVAX deal closed today?
2 · Reply